Pro- and anti-inflammatory biomarkers in non-alcoholic fatty liver disease and hypertension patients
Loading...
Date
Editor(s)
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Non-alcoholic fatty liver disease (NAFLD) affects up to 50% of patients with hypertension (HT). The objective of our study was to assess the changes in anti-inflammatory systems (kallistatin, IL-10) and pro-inflammatory activity (IL-1β and high-sensitivity CRP (hsCRP)) in patients with NAFLD under the influence of concomitant HT.
Description
Keywords
Citation
Rozhdestvenska A. Pro- and anti-inflammatory biomarkers in non-alcoholic fatty liver disease and hypertension patients/ A. Rozhdestvenska, N. Zhelezniakova // 1st International Conference For Young Scientists – Biomarkers Of Civilization Diseases, April 21, 2023, Poland, Bialystok : Book of Abstracts. – Bialystok, 2023. – P. 94.